NuMedica is the premiere manufacturer of professional nutrition formulas exclusively available through licensed healthcare practitioners
The battle over America's booming weight-loss drug market has a significant update, with a move thats likely to cause a shift across the healthcare and corporate benefits landscape: Cigna, one of Americas biggest insurers, is dropping coverage for GLP-1 obesity drugs, even for its own staff
Collin Dees, PA-C, who leads weight loss care at Med Matrix alongside Sophia Viner, DNP, ANP-BC, points to the delivery method itself as the difference: an FDA-approved pen delivers a fixed, pre-measured dose, while a vial and syringe leave the math to whoever is holding the needle at home
Research shows that delayed gastric transit can reduce mineral bioavailability by extending the time nutrients spend in the digestive tract, potentially leading to inadequate absorption
In its release, Eli Lilly said it plans to submit an application to the FDA and to regulatory agencies in other countries seeking approval of the drug for treating sleep apnea in people with obesity